text: To develop a cycle-based risk prediction model for neutropenic complications ( NC ) during chemotherapy with doxorubicin ( DOX ) or a pegylated liposomal formulation ( PLD ) for patients with metastatic breast cancer ( MBC ) .
entities.text: doxorubicin ( DOX )
entities.type: intervention
entities.text: pegylated liposomal formulation ( PLD )
entities.type: intervention
entities.text: cycle-based risk prediction model for neutropenic complications ( NC )
entities.type: outcome
entities.text: patients with metastatic breast cancer ( MBC )
entities.type: participant